検索
Select region
Close filter

Sandy Zhang

連絡先

+86 21 2401 8228

Sandy Zhang, based in Shanghai, is a core member in Egon Zehnder’s Health Practice. She has deep expertise in board search and consultancy, leadership development, cross-border executive search, and leadership enhancement in the area of R&D and innovation.

I am passionate about helping Chinese companies to go global, at the same time about supporting multinational players to thrive in China.

Prior to joining Egon Zehnder, Sandy was Project Manager for Bayer and Director of Business Development and Strategy and Director of Marketing for Philips Healthcare in China. Previously, she served as a Business Consultant at Bain & Company, where she advised clients on China entry strategy, post-merger integration, and organizational design.

Sandy has a BS in biology from Zhongshan University in China and an MS in molecular biology and an MBA from Cornell University in the U.S

张晓馨是亿康先达健康产业咨询团队的活跃成员。她在高管寻访,跨境人才寻访、董事会建设、领导力开发、研发创新领域领导力提升等方面均有深厚经验。她致力于帮助跨国医疗医药企业在中国长足发展,以及助力中国本土企业成为全球大健康领域的领跑者。

对于帮助中国企业走向全球、以及支持跨国企业在中国蓬勃发展的事业,我都极具热情。

加入亿康先达之前,张晓馨曾任德国拜耳公司战略咨询部项目经理和飞利浦医疗保健事业部中国区业务拓展与战略总监、战略市场总监。在此之前,她曾服务于贝恩咨询,为多家财富五百强企业提供中国战略规划、收购兼并、组织构建等各类企业战略咨询。

张晓馨是中山大学生物学学士、美国康奈尔大学分子生物学硕士与MBA。

連絡をとる
Sandy Zhangにメッセージを送る
Browse all
Thought Leadership

関連するコンサルタント

Anja-Maria Klodwig

Anja-Maria Klodwig

Düsseldorf

Anja-Maria Klodwig, based in Düsseldorf, is active in Egon Zehnder’s Health and Industrial Practice. 詳細

Christian Schmidt

Christian Schmidt

Johannesburg, London

Christian Schmidt, based in London, focuses on the industrial sector, assisting clients in natural resources, process, and manufacturing industries… 詳細

Lisa Blais

Lisa Blais

Boston

Lisa Blais serves on Egon Zehnder’s Board of Directors and leads the firm’s US Board Practice. She also recently served as Managing Partner of… 詳細

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top